Evidence map›Paper›PMID 33420409›Full record

ArticleCommunications biology2021

Streamlined copper defenses make Bordetella pertussis reliant on custom-made operon.

Alex Rivera-Millot, Stéphanie Slupek, Jonathan Chatagnon, Gauthier Roy, Jean-Michel Saliou, Gabriel Billon, Véronique Alaimo, David Hot, Sophie Salomé-Desnoulez, Camille Locht and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. CrpH ofFrontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Conquering the host:Frontiers in microbiology · 2022
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Alex Rivera-MillotUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Stéphanie SlupekUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Jonathan ChatagnonUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Gauthier RoyUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Jean-Michel SaliouUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UMS 2014 - PLBS, F-59000, Lille, France.ORCID http://orcid.org/0000-0003-0105-5196
Gabriel BillonUniv. Lille, CNRS, UMR 8516 - LASIRE - Laboratoire de Spectroscopie pour les Interactions, la Réactivité et l'Environnement, F-59000, Lille, France.
Véronique AlaimoUniv. Lille, CNRS, UMR 8516 - LASIRE - Laboratoire de Spectroscopie pour les Interactions, la Réactivité et l'Environnement, F-59000, Lille, France.
David HotUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UMS 2014 - PLBS, F-59000, Lille, France.ORCID http://orcid.org/0000-0002-2361-0616
Sophie Salomé-DesnoulezUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Camille LochtUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
Rudy AntoineUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France. rudy.antoine@inserm.fr.
Françoise Jacob-DubuissonUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019- UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France. francoise.jacob@ibl.cnrs.fr.ORCID http://orcid.org/0000-0002-5102-1704
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper is both essential and toxic to living beings, which tightly controls its intracellular concentration. At the host-pathogen interface, copper is used by phagocytic cells to kill invading microorganisms. We investigated copper homeostasis in Bordetella pertussis, which lives in the human respiratory mucosa and has no environmental reservoir. B. pertussis has considerably streamlined copper homeostasis mechanisms relative to other Gram-negative bacteria. Its single remaining defense line consists of a metallochaperone diverted for copper passivation, CopZ, and two peroxide detoxification enzymes, PrxGrx and GorB, which together fight stresses encountered in phagocytic cells. Those proteins are encoded by an original, composite operon assembled in an environmental ancestor, which is under sensitive control by copper. This system appears to contribute to persistent infection in the nasal cavity of B. pertussis-infected mice. Combining responses to co-occurring stresses in a tailored operon reveals a strategy adopted by a host-restricted pathogen to optimize survival at minimal energy expenditure.

Indexed as

OperonBordetella bronchisepticaBordetella pertussisCopperHomeostasisPeroxidesCopperPeroxides

Identifiers

PMID33420409
PMCPMC7794356
OpenAlexW3120326780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.